[1] 李琦, 黄兴涛, 柳彬,等. 118例肺结核的不典型CT表现[J].重庆医学, 2014,26(19):2478-2480. [2] 李明. 利福布丁不同给药方法治疗耐多药结核病疗效对比研究[J].中国实用医药, 2015,31(25):139-140. [3] 高宁, 郭元霞, 张小云,等. 肺结核患者营养风险状况及其影响因素的研究[J].中华护理杂志, 2014, 49(5):552-555. [4] Swaminathan S, Sangeetha M, Arunkumar N,et al. Pulmonary tuberculosis in HIV positive individuals: preliminary report on clinical features and response to treatment [J].Indian J Tuberc,2002, 49(4):189-193. [5] Kolappan C, Subramani R. Association between biomass fuel and pulmonary tuberculosis: a nested case-control study [J].Thorax,2009 ,64(8):705-708. [6] Buregyeya E, Criel B, Nuwaha F, et al. delays in diagnosis and treatment of pulmonary tuberculosis in wakiso and mukono districts, uganda [J].BMC Public Health,2014, 14(1):1-10. [7] Xu DD, Deng DF, Li X, et al. Discovery and identification of serum potential biomarkers for pulmonary tuberculosis using iTRAQ-coupled two-dimensional LC-MS/MS.[J].Proteomics,2014 ,14(2-3):322-331. [8] Zar HJ, Workman LJ, Little F, et al.Diagnosis of pulmonary tuberculosis in children: assessment of the 2012 national institutes of health expert consensus criteria[J].Clin Infect Dis,2015,61(Suppl 3):S173-S178. [9] 谭守勇, 丁秀秀, 谭耀驹,等. 异烟肼和利福平治疗方案对单耐异烟肼或利福平肺结核患者的治疗效果[J].中华结核和呼吸杂志, 2014, 37(12):915-918. [10] 孔雯, 刘巧, 陆伟,等. 标准化耐多药肺结核化疗方案的不良反应及治疗转归情况分析[J].中华疾病控制杂志, 2014, 18(7):610-612. [11] 吴惠忠, 周琳, 蒋莉,等. 375例耐多药肺结核二线抗结核药物敏感性状况分析[J].实用医学杂志, 2014,38(14):2315-2317. [12] Sabri A, Grant AV, Cosker K, et al. Association study of genes controlling IL-12-dependent IFN-γ immunity: STAT4 alleles increase risk of pulmonary tuberculosis in Morocco [J].J Infect Dis,2014 ,210(4):611-618. [13] 文强, 张红, 马云波. 磺胺甲噁唑联合抗结核药物对结核杆菌的体外抑菌作用[J].山东医药, 2016, 56(40):91-93. [14] 李史来, 陈伟生, 黄钥藩,等. 含左氧氟沙星联合利福布丁方案治疗复治肺结核患者的疗效观察[J].中国防痨杂志, 2014, 36(5):375-379.
2017, Vol. 34 
